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Radiation doses to patients resulting from chest X-ray examinations were evaluated in four medical centers in the West Bank
and East Jerusalem—Palestine. Absorbed organ and effective doses were calculated for a total of 428 adult male and female
patients by using commercially available Monte Carlo based softwares; CALDOSE-X5 and PCXMC-2.0, and hermaphrodite
mathematical adult phantoms. Patients were selected randomly from medical records in the time period from November 2014
to February 2015. A database of surveyed patients and exposure factors has been established and includes: patient’s height,
weight, age, gender, X-ray tube voltage, electric current (mAs), examination projection (anterior posterior (AP), posterior
anterior (PA), lateral), X-ray tube ﬁltration thickness in each X-ray equipment, anode angle, focus to skin distance and X-ray
beam size. The average absorbed doses in the whole body from different projections were: 0.06, 0.07 and 0.11 mGy from AP,
PA and lateral projections, respectively. The average effective dose for all surveyed patients was 0.14 mSv for all chest X-ray
examinations and projections in the four investigated medical centers. The effect of projection geometry was also investigated.
The average effective doses for AP, PA and lateral projections were 0.14, 0.07 and 0.22 mSv, respectively. The collective
effective dose estimated for the exposed population was ~60 man-mSv.
INTRODUCTION
The need for using medical X-ray examinations is
increasing around the world(1). Medical applications
of ionizing radiation are deﬁned as the second source
of exposure to man after the natural sources of
radioactivity(2). The exposure mainly comes from
medical X-ray usage to patients in diagnosis and
therapy. Researches on low radiation dose indicate
that, there is an increase in the risk of stochastic det-
riment from diagnostic X-ray. Therefore, radiation
dose to patient must be kept as low as reasonably
achievable (ALARA)(3). Many studies evaluated
radiation doses from medical X-ray examinations
and risk assessment from their collective doses.
Organ dose, the absorbed amount of radiation in a
radiosensitive organ is usually used for estimating
radiation risks to the patients. The United Nations
Scientiﬁc Committee on the Effects of Atomic
Radiation (UNSCEAR) reported an increase in the
annual number of medical diagnostic examinations
as well as the annual collective effective dose from
diagnostic medical examinations(4). Effective dose is
a radiation protection quantity calculated with
selected weighting factors to get a single number that
represents the health detriment to the whole body.
Effective dose has proved to be a useful tool in con-
trolling exposures received by patients undergoing
medical diagnostic and interventional procedures.
However, its use to provide estimates of risk to indi-
vidual patients goes beyond its intended use(1, 5).
Brenner(6) suggested that effective dose should be
replaced by effective risk as a more scientiﬁcally
based quantity.
X-ray imaging represents the main source of med-
ical radiation exposure worldwide, and those exami-
nations have high values in medical and diagnostic
ﬁelds(7). Low cost of using conventional X-ray
imaging during the past century has made it a com-
mon daily diagnostic tool. However, it is important
that radiation doses from X-ray examinations are
being monitored, and kept at a minimum. Chest X-
ray examination is considered as the most conven-
tional diagnostic radiography examination because it
has a high value for diagnosing a wide range of
health issues. Although recent developments in cross
sectional imaging of the thorax exist, particularly
computed tomography, this examination provides
very important information for diagnosis, treatment
and follow-up procedures of many pulmonary dis-
eases. Chest radiography has many advantages over
cross sectional imaging, such as lower cost, lower dose,
speed of acquisition and diagnosis(8). Assessment and
optimization of radiation doses received by patients
are some of the most important tasks for radiation
protection of patients in diagnostic radiology. Chest X-
ray examination may also be implemented in screening
programs for large populations, with a signiﬁcant
impact on the collective dose(9).
Palestine is a country that has shown an increase
in the use of radiation in medical diagnosis. This
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increase is accompanied with a lack of information
about the radiation dose received by patients.
Moreover, there is a lack of quality control, which
should be undertaken to get better diagnostic infor-
mation with minimal X-ray exposure to patients.
According to the Palestinian Medical Imaging
Association (PMIA), in 2013, there were 176 hospi-
tals and medical centers in the West Bank with
X-ray Departments. About 134 plain X-ray and port-
able machines can be found in those hospitals and
centers(10). The total number of utilization of plain
X-ray in governmental hospitals was about 803,913
images in the West Bank, which forms ~83.5% of all
medical X-ray usage, and ~53% constitutes the total
number of chest X-ray images(11). Scientiﬁc studies
on patients doses from X-ray examinations are in
Palestine. Practical regulations lack clear instructions
for radiation protection and safety guidelines. The
knowledge of radiation protection is quite poor.
Radiation protection and quality control programs
are not available in many healthcare centers in the
country. Estimating the organ and effective doses is
a solution to get a view of medical radiation expos-
ure to patients. In routine radiological procedures, it
is not practical to conduct in vivo measurements of
organ doses. The possible practical methods for
deriving the organ doses are measurements in a
phantom, i.e. an artiﬁcial object representing a
patient, or computer calculations. An important
method applicable to a wide range of applications is
Monte Carlo (MC) simulation, MC uses phantoms,
which are deﬁned as artiﬁcial objects, representing a
patient or computer calculations(12, 13). As stated
above, effective dose should not be used to assess
risks to individual patients of speciﬁc age, sex and
nationality, an application for which it was not
intended. It can, however, be a valuable tool for
comparing the doses (and risks of aggregated detri-
ment) to a reference person (of ‘average’ age, gender
and nationality) from different medical diagnostic
procedures and from other sources of radiation
exposure(14). The aim of this work is to evaluate the
organ doses and effective doses for patients undergo-
ing chest X-ray radiography in different projections.
MATERIALS AND METHODS
Data concerning a total of 428 male and female
adult patients undergoing chest X-ray examination
in different projections were collected from four
medical centers between November 2014 and
February 2015. Investigated medical centers utilize
plain X-ray radiographic systems as well as portable,
while one center uses computed radiography (CR).
Radiographic systems used in the four medical cen-
ters and exposure factors for all projection geom-
etries are summarized in Table 1.
Evaluation of organ absorbed doses and effective
doses was performed theoretically using two com-
mercially available softwares based on MC simula-
tions: CALDose_X (Calculation of dose for X-ray
diagnosis) is a software tool that provides the possi-
bility to calculate incident air Kerma (INAK) and
entrance surface air Kerma (ESAK), two important
quantities used in X-ray diagnosis, based on the out-
put of the X-ray equipment(15). The second used
software is PCXMC, which is a code for calculating
patient doses in diagnostic radiology developed at
the Medical Radiation Laboratory of the Finnish
Radiation and Nuclear Safety Authority. The ﬁrst
version PCXMC (PC program for X-ray Monte
Carlo) was released in 1997 for calculating patient
organ dose and estimating effective dose in medical
diagnostic X-ray examinations. It allows a free
adjustment between the X-ray projections from
many X-ray examination types.
The phantoms used in PCXMC are computational
hermaphrodite phantoms representing human beings of
various ages: new-born, 1, 5, 10, 15 years old and adult
patients. The phantoms include expressions describing
various organs and body parts. These phantoms have
been speciﬁed by Cristy and Eckerman (1987) with
Table 1. Exposure factors in the four selected medical centers H1, H2, H3 and H4.
Medical center H1 H2 H3 H4
Radiographic system Plain X-ray Plain X-ray Plain X-ray Computed
radiography
Exposure factors AP portable PA LAT AP portable PA LAT PA PA LAT
kVp (KeV) 50–75 100–120 105–125 62–74 75–95 88–105 70–95 109–133 120–133
mAs 5–15 1–4 4–12 5–8 5–6 16–25 10–25 3–9.5 4–14
FID (cm) 100 180 180 100 180 100 180 180 180
FID: focus image distance, CR: computed radiography, AP: anterioposterior projection, PA: posterioanterior projection,
LAT: lateral projection, mAs: milliamperage second, kVp: kilovoltage peak, AP portable: anterioposterior projection in
portable radiography.
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further modiﬁcations; (modiﬁcation of the head, correc-
tion of some apparent errors in the data of Cristy and
Eckerman and inclusion of some new organs: extra-
thoracic airways, oral mucosa, prostate and salivary
glands). These modiﬁcations of the phantom enable the
calculation of the effective dose using the tissue weight-
ing factors introduced in ICRP Publication 103 (2007).
Also, the program has organized doses for patients with
different ages and sizes and for different projections. In
the calculation, the user can specify whether the arms
of the phantom are included at the sides of the trunk or
whether they are removed (which may simulate the real
situation better, e.g. for lateral projections). Trunk width
is given for both of these conditions(16, 17).
Initially, for effective dose calculations, the Entrance
Skin Air Kerma (ESAK) and the Incident Air Kerma
INAK have to be estimated from the X-ray tube out-
put parameters. Personal data and X-ray tube expos-
ure parameters were recorded for all patients. These
factors are: kVp, mAs, the FFD, patient age and gen-
der. The ESAK and INAK values were estimated
from the X-ray tube geometry parameters by using
(CALDose_X) software, while PCXMC was used to
calculate organ and effective doses. PCXMC software
calculates the effective dose using tissue weighting fac-
tors of ICRP 103 and ICRP 60, and gives the average
absorbed doses in the whole body.
RESULTS AND DISCUSSION
The absorbed organ doses were calculated for 29
body organs for every patient. The average organ
doses were evaluated from all patients in anterior
posterior anterior (AP), posterior anterior (PA) and
lateral projections. PA and lateral projections in
chest radiography account for more than 75%, of
chest X-ray examinations. In case of incapacitated
patients, AP projection was performed by portable
X-ray machine. Calculations of organ and effective
doses were conducted while a patient is positioned
with arms in PA and AP projections and without
arms in lateral projections. The highest average
organ dose was 0.56 mGy and received by breasts in
LAT projection. Breasts received also the highest
dose in AP projection, ~0.56 mGy. While the highest
average dose in PA projection was found for lungs,
~0.23 mGy. Relatively high doses were received by
spleen in both PA and LAT projections, while heart
receives high doses in AP and LAT projections.
Skeleton is exposed approximately to the same radi-
ation dose in the all three projections. The organs
exposed to the lower doses in all projections of chest
X-ray were brain, testicles, urinary bladder and
uterus. Figure 1 presents the average organ doses for
all surveyed patients.
The average effective dose was also calculated for
all routine projections of chest radiography in the
participating medical centers. Figure 2 shows the
average effective doses evaluated for all patients.
Table 2 presents the average absorbed doses, effective
doses and ESAK, calculated for different projections
for a number of patients from medical center H1.
Higher average ESAK in lateral projection com-
pared to PA projection means high amount of
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Figure 1. Average absorbed organ doses for all patients from chest X-ray in AP, PA and LAT projections.
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backscatter radiation because the thickness of
patient increases laterally. ESAK includes the back-
scattered radiation from the patient. However, the
higher value of ESAK in AP projection is due to the
use of portable radiographic system in which higher
mAs and lower source to image distances (SID) are
applied (the SID in portable radiography is ~100 cm,
while in ﬁxed installations is ~180 cm). Low doses in
PA projection are because of the application of low
mAs (tube current-exposure time product values
range from 1 to 4 mAs, kVp range is 100–120 kV).
PA projection is routinely used in chest radiography
due to lower body thickness and it is also a better
projection for radiation protection of the breast and
thyroid. Calculations of effective dose based on
ICRP 103 weighting factors in the case of chest X-
ray provide slightly higher values than that based on
ICRP 60. This is due to the differences in weighing
factors. While the ICRP 60 recommend a weighing
factor of 0.05 for the breast, which is an important
organ in chest X-ray imaging, the ICRP 103 recom-
mends 0.12, also in the ICRP 60 the recommended
weighing factor for the reminders is 0.05, while its
0.12 in the ICRP 103. Results of effective dose calcu-
lations for all medical centers and projections are
shown in Figure 2.
Lateral projections resulted in the highest radi-
ation doses at all investigated medical centers, even
while using CR. Exposure factors in LAT projection
are higher than in PA and AP procedures. In LAT
projection, the value of mAs is three to four times
higher than mAs for AP and PA projections, depend-
ing on patient’s size.
The highest value of effective dose (0.39 mSv) was
found in medical center H2, where a short FID was
applied (100 cm instead of 180 cm). The reason is
not clear why this short FID was applied. Probably,
it was a mistake provided by the radiation technolo-
gist. PA projection in CR resulted in higher or equal
doses than plain X-ray in other medical centers. In
this case, both mAs and kVp in CR PA projection
are higher than those in plain radiography. Portable
radiography in general, provides higher doses to the
patients because of higher mAs values and shorter
FID. However, all evaluated effective dose values in
this work are comparable with results published in
other countries. The effective dose from chest radiog-
raphy was estimated in many regions of the world.
Those doses can vary between different countries
depending on the processing techniques, technical
exposure factors, patient’s geometry and biological
features. Table 3 presents a comparison between
effective dose values obtained in this study and those
reported from different countries(18–23).
In general, the average annual effective dose to
population from diagnostic medical X-ray examinations
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Figure 2. Average effective doses evaluated for patients from all medical centers.
Table 2. Average absorbed dose, effective dose and ESAK evaluated for 267 patients from medical center H1.
Dose Projection
AP PA LAT
Average effective dose ICRP 103 (mSv) 0.15 0.04 0.12
Average effective dose ICRP 60 (mSv) 0.10 0.04 0.10
Average absorbed dose in the whole body (mGy) 0.07 0.04 0.07
Average ESAK (mGy) 1.16 0.28 1.08
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varies from <0.02 to 1.2mSv depending on health care
level. Worldwide average annual effective dose is 0.4
mSv(24). The collective effective dose was estimated by
multiplying the total number of patients and the average
effective dose from all chest X-ray projections and found
to be ~60 man-mSv.
CONCLUSION
Results obtained in this work are comparable with
the results published from different countries. The
average effective dose evaluated in this study is very
close to those received by the European population.
Many of the Palestinian medical centers dealing with
medical applications of radiation does not have clear
policies and strategies for radiation protection prac-
tices nor quality control programs. Furthermore,
diagnostic reference levels do not exist in the coun-
try. Variation of organ and effective doses evaluated
in this study suggested that there is a space for stand-
ardization of the radiological techniques and for
optimizing radiographic procedures to reduce patient
dose. We believe that this work will contribute to the
establishment of a national radiation protection pro-
gram with clear strategy and vision for minimizing
the radiation doses received by the population from
medical uses of radiation.
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